Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Immunity|May 13, 2020
Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control MechanismsJean-Christophe Beltra, Sasikanth Manne, Mohamed S Abdel-Hakeem, et al.
British Journal of Cancer|October 16, 2018
A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumoursAmit Maity, Rosemarie Mick, Alexander C Huang, et al.
JAMA Dermatology|September 18, 2024
Inherited Basaloid Neoplasms Associated With SUFU Pathogenic VariantsJames J Abbott, Angela J Jiang, Rama Godse, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 6, 2019
First-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion TargetingNeeta Pandit-Taskar, Michael A Postow, Matthew D Hellmann, et al.
Nature Immunology|October 21, 2022
Shared and distinct biological circuits in effector, memory and exhausted CD8+ T cells revealed by temporal single-cell transcriptomics and epigeneticsJosephine R Giles, Shin Foong Ngiow, Sasikanth Manne, et al.
Immunity|March 9, 2022
Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancersJosephine R Giles, Sasikanth Manne, Elizabeth Freilich, et al.
Cell Reports|October 8, 2023
Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunityWenqun Zhong, Youtao Lu, Xuexiang Han, et al.
Cancer|July 22, 2021
Compliance with sentinel lymph node biopsy guidelines for invasive melanomas treated with Mohs micrographic surgeryKelly M MacArthur, Brian C Baumann, Joseph F Sobanko, et al.
European Journal of Cancer (Oxford, England : 1990)|December 28, 2020
Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanomaCaroline Robert, Wen-Jen Hwu, Omid Hamid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2022
BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant MelanomaJanice M Mehnert, Tara C Mitchell, Alexander C Huang, et al.
Pageof 8